Results 211 to 220 of about 80,664 (276)

The role of dopamine decline, astrocyte reactivity, and cerebral small-vessel disease in cognitive aging. [PDF]

J Cereb Blood Flow Metab
Crine V, Johansson J, Ericsson O, Wåhlin A, Axelsson J, Anderssson M, Nyberg L, Karalija N.   +7 more
europepmc   +1 more source

Case Report: Four cases for cariprazine and alcohol use disorder. [PDF]

Front Psychiatry
Vicentic S.
europepmc   +1 more source

Emerging Neurobiological and Therapeutic Insights into Schizophrenia: A Comprehensive Review. [PDF]

Int J Mol Sci
Oatu A, Capatina TF, Mandras IC, Comsa AL, Trifu S, Pietreanu AC.   +5 more
europepmc   +1 more source

Loss of Thy1 in Cortico-Striatal Pathways Alters Response to Dopamine and Gabapentin. [PDF]

ASN Neuro
Goletiani C, McEchron MD, Neely E, Connor JR.   +3 more
europepmc   +1 more source

Targeting the hypothalamic a11 nucleus to treat parkinsonian-like nociceptive impairments. [PDF]

NPJ Parkinsons Dis
Charles KA, Bouali-Benazzouz R, Naudet F, Aby F, Fossat P, Benazzouz A.   +5 more
europepmc   +1 more source

Structural Basis for D3/D4-Selective Antagonism of Piperazinylalkyl Pyrazole/Isoxazole Analogs. [PDF]

Molecules
Choi KE, Jang SH, Park WK, No KT, Koh HY, Pae AN, Cho NC.   +6 more
europepmc   +1 more source

Focused Ultrasound for the Treatment of Circuit and Molecular Pathology in Parkinson's Disease. [PDF]

Mov Disord
Kofoed RH, Hvingelby VS, Pineda-Pardo JA, Blesa J, Paschen S, Tandon A, Joutsa J, Glud AN.   +7 more
europepmc   +1 more source

Dynamics of synchronous bursts in functionally coupled midbrain dopamine neurons driven by diverse excitatory inputs. [PDF]

Front Syst Neurosci
Chen MJ.
europepmc   +1 more source